Medications Prescribed for Life After Myocardial Infarction

Core Medications for Lifelong Use

• The American College of Cardiology recommends aspirin (75-325 mg daily) to be continued indefinitely in all post-MI patients unless contraindicated, as it reduces mortality and prevents recurrent cardiovascular events 1, 3
• The American College of Cardiology suggests considering clopidogrel 75 mg daily as an alternative to aspirin if aspirin is contraindicated 3
• The European Heart Journal recommends beta-blockers (such as metoprolol, propranolol, timolol, acebutolol, or carvedilol) to be started in all post-MI patients and continued indefinitely, reducing mortality and reinfarction by 20-25% 1, 2, 4
• The American College of Cardiology recommends ACE inhibitors to be prescribed to all patients post-MI and continued indefinitely, particularly in patients with reduced left ventricular function 1, 3, 5
• The European Heart Journal suggests that if ACE inhibitors are not tolerated, consider angiotensin receptor blockers (ARBs) as an alternative 2
• The American College of Cardiology recommends statin therapy to be initiated or intensified in all post-MI patients regardless of baseline LDL levels, with a target LDL cholesterol of <100 mg/dL 1, 3, 6

Additional Medications Based on Specific Conditions

• The American College of Cardiology recommends appropriate hypoglycemic therapy to achieve near-normal fasting plasma glucose for patients with diabetes 1
• The European Heart Journal suggests more aggressive blood pressure and lipid management may be beneficial for patients with diabetes 5
• The European Heart Journal recommends higher doses of ACE inhibitors for patients with heart failure post-MI 5
• The European Heart Journal suggests considering adding aldosterone antagonists for patients with reduced ejection fraction 2
• The European Heart Journal recommends calcium channel blockers (verapamil or diltiazem) as alternative treatments for patients with contraindications to beta-blockers, particularly in patients with obstructive airway disease 4

Medication Adherence and Follow-up

• The American College of Cardiology emphasizes the importance of regular follow-up to monitor medication efficacy, adjust dosages if needed, and assess for adverse effects 3

Common Pitfalls and Caveats

• The European Heart Journal notes that nitrates have not been shown to improve long-term prognosis after MI 4
• The European Heart Journal states that calcium channel blockers have weaker evidence for benefit compared to beta-blockers 4